83
Participants
Start Date
October 31, 2007
Primary Completion Date
January 31, 2011
Study Completion Date
January 31, 2011
Interferon-1beta (Betaseron, BAY86-5046)
Patients with a first demyelinating event suggestive of MS, as well as patients with remittent recurrent MS (RRMS), secondary progressive MS (SPMS) and primary progressive MS (PPMS) will be observed.
Many Locations
Lead Sponsor
Bayer
INDUSTRY